Stony Brook Community Medical PC - Island Fertility – FDA 483, May 28, 2024
Stony Brook Community Medical PC - Island Fertility, a reproductive human tissue establishment, was cited for significant deficiencies in donor eligibility determination, screening, testing, and labeling of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The inspection revealed instances where donors with positive communicable disease tests or incomplete screening were deemed eligible, and HCT/Ps from ineligible donors were not properly labeled with biohazard warnings. Additionally, the firm's standard operating procedures for donor screening lacked clear criteria, potentially allowing ineligible tissues to proceed without proper evaluation.
- Inspection date
- May 28, 2024
- Product type
- biologics
ID · 7f0f8dde-2621-414d-938c-c01e21fcf267
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.